LIFE-ME: Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development!

Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development! Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the Global International Leaders in the field of Nanosensing Technology as a new member of the Scientific Advisory Board for the Sencell Development. "Prof. Huth is an outstanding scientist and will bring extremely valuable support to the existing advisory board, which is already composed of leading international experts in the field of diabetes and diabetes technology" says Prof. Andreas Pfützner, Chief Scientific Officer of Lifecare and Christian Torp Saure, Lifecare's Executive Chairman, adds: "Having Prof. Huth join our advisory board is not only a major achievement in the atempt to finalize the Sencell development, but also a further proof for the acceptance by the scientific community of Lifecare's Sencell development and for the companies' vision to help people suffering from diabetes." In addition to Prof Huth the Lifecare AS' Scientific Advisory Board includes: Chairman: Prof. David C. Klonoff - Clinical Professor of Medicine, University of California San Francisco - Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center - Editor in Chief, Journal of Diabetes Science and Technology - Chairman, Diabetes Technology Meeting Member: Prof. Lutz Heinemann - Founding Partner, Profil Institute for Metabolic Research in Neuss, Germany - Member of the German Diabetes Association (DDG), the European Association for the Study of Diabetes (EASD)and the American Diabetes Association (ADA) - Co-Editor, Journal of Diabetes Science and Technology - Awarded for “Leadership in Diabetes Technology” and “Artificial Pancreas Research Award” from the Diabetes Technology Society Member / CMO: Prof. Kåre Birkeland - Professor of Internal Medicine and Endocrinology, University of Oslo - Senior consultant in Endocrinology, Dep. of Transplantation Medicine, Rikshospitalet, Oslo University Hospital - Chairman Advisory Board, Norwegian Diabetes Association About Lifecare Lifecare is a Norwegian life-science company, headquartered in Bergen. The Company was incorporated on 4 September 2006. Lifecare is developing an implantable continuous monitoring device and technology, Sencell Glucose Sensor, for glucose assessment. Lifecare has the intellectual property rights to the underlying nanotechnology and MEMS-technology to realize the product development. Lifecare recently entered a Joint Venture with IMS Capital Partners GmbH founding Digital Diagnostics AG to finalize the Sencell development. For more information or interviews, please contact: Christian Torp Saure Chairman, Lifecare + 47 90933148 christian@sternacap.no
http://www.newsweb.no/newsweb/search.do?messageId=493578